In this interview recorded on April 29, 2020, we discussed the current state and future prospects of the several oversight panels established to oversee the federal government’s COVID-19 relief spending.
Topics include:
The new Special Inspector General for Pandemic Recovery (SIGPR). What's the outlook on Brian Miller's nomination? What can we expect from this office? What is SIGPR most needed for?
The Pandemic Response Accountability Committee (PRAC). Actions by President Trump disrupted early efforts to jumpstart this body. What's happened since then? Who's involved, and what should Americans look for from the PRAC?
The Congressional Oversight Commission (COC). Congressional leaders have appointed four of five members, but where's the chair? What are the prospects for this body, and how does it complement—or conflict with—the others?
The new House Select Committee on the Coronavirus Crisis (SCCC). It was created by House Speaker Nancy Pelosi and faces skepticism from Republicans. Pelosi's decision to name Rep. Donna Shalala (D-FL) to the committee caused alarm when it was reported the congresswoman's own financial transparency fell short. So what is the SCCC? Is a fourth body necessary? How is it different from the COC?
